TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR

aTyr Pharma faces a class action lawsuit after announcing disappointing clinical trial results for Efzofitimod, causing an 83.2% stock price drop in a single day.

Insights
HAS   neutral

Mentioned in context of licensing deal with Netflix, but no specific performance details provided


ATYR   negative

Stock price dropped 83.2% after failing to meet primary endpoint in EFZO-FIT study, with potential legal action from investors alleging securities fraud